Axsome Therapeutics Reveals Findings from the CRESCENDO Narcolepsy Patient Survey Highlighting Unmet Requirements in Treated Narcolepsy Type 1 Individuals

Source :: Plus Company Updates. March 25, 2024
Publication Year :: 2024
Abstract: NEW YORK: Axsome Therapeutics, a biopharmaceutical company, has announced the results of a survey conducted in partnership with Narcolepsy Network, a national non-profit organization for people with narcolepsy, idiopathic hypersomnia, [...]

Subjects :: Medical research -- Surveys
Medicine, Experimental -- Surveys
Health surveys -- Surveys
Patient satisfaction -- Surveys
Narcolepsy -- Care and treatment
General interest
News, opinion and commentary
Narcolepsy Network -- Surveys

Tools